Piper Jaffray Starts Nanosphere (NSPH) at Buy
Tweet Send to a FriendGet Alerts NSPH Hot Sheet
Price: $3.79 +2.43%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade NSPH Now!
Piper Jaffray initiates coverage on Nanosphere (Nasdaq: NSPH) with a Buy rating and a $17 price target.
The firm said Nanosphere's core technology is solid and its recent FDA approval for its Verigene molecular diagnostics instrument will lead to long-term revenue growth.
Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform.
The firm said Nanosphere's core technology is solid and its recent FDA approval for its Verigene molecular diagnostics instrument will lead to long-term revenue growth.
Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform.
You May Also Be Interested In
- Topeka Capital Starts Diodes (DIOD) at Buy
- Deutsche Bank Upgrades Seagate (STX) to Buy; Sanmina (SANM) Cut to Sell, Flextronics (FLEX) & Fabrinet (FN) Cut to Hold
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
